eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | barrett esophagus |
| Symptom | |adenocarcinoma |
| Sentences | 56 |
| PubMedID- 22272378 | found a correlation between cox2 expression and tp53 wild-type status in esophageal adenocarcinoma with barrett's esophagus as a precursor lesion, but not in scc, providing evidence that the participation of p53 in the regulation of cox2 expression in cancer may be dependent on tumor histology. |
| PubMedID- 21375764 | In contrast with the esophageal adenocarcinoma arising from barrett's esophagus in western countries, the major phenotype in the asia-pacific region is esophageal squamous cell carcinoma (escc) . |
| PubMedID- 22353776 | Observational data have also indicated that statins may have protective effects against the development of cancer, for example, modifying the risk of oesophageal adenocarcinoma in patients with existing barrett's oesophagus . |
| PubMedID- 24765592 | In this present study by qumseya et al.,13 among 136 patients with adenocarcinoma or dysplasia of barrett's esophagus, 27% had esophageal stricture. |
| PubMedID- 25502158 | The goal of this study was to determine whether the use of metformin modifies the risk of development of esophageal adenocarcinoma in patients with barrett esophagus. |
| PubMedID- 22443641 | Previously, the risk of progression to esophageal adenocarcinoma in patients with barrett's esophagus was thought to be approximately 1%. |
Page: 1 2